the cholesterol lowering atherosclerosis study ( clas ) is a prospective , placebo-controlled , angiographic trial designed to test the hypothesis that aggressive lowering of ldl cholesterol with concomitant increase in hdl cholesterol will reverse or retard the atherosclerotic process .
C0008377
clas
C0023824
ldl cholesterol